2,5-Dichloroiodobenzene
CAS29682-41-5
2,5-Dichloroiodobenzene (CAS 29682-41-5, C6H3Cl2I) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 29682-41-5
- Formula
- C6H3Cl2I
- Mol. weight
- 272.9 g/mol
- Appearance
- Clear colourless to brownish liquid
Chemical Specifications
Identifiers
| CAS number | 29682-41-5 |
|---|---|
| Product name | 2,5-Dichloroiodobenzene |
| Synonyms | 1,4-DICHLORO-2-IODOBENZENE |
| Molecular formula | C6H3Cl2I |
| Molecular weight | 272.9 g/mol |
| EC number | 249-774-3 |
| InChI | InChI=1/C6H3Cl2I/c7-4-1-2-5(8)6(9)3-4/h1-3H |
Physical and chemical properties
| Appearance | Clear colourless to brownish liquid |
|---|---|
| Melting Point | 21-257 ( ℃ ) |
| Boiling Point | 93.9 ( ℃ ) |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of 2,5-Dichloroiodobenzene?
The CAS Registry Number of 2,5-Dichloroiodobenzene is 29682-41-5. 2,5-Dichloroiodobenzene is also known as 1,4-DICHLORO-2-IODOBENZENE.
What is the molecular formula and molecular weight of 2,5-Dichloroiodobenzene?
The molecular formula of 2,5-Dichloroiodobenzene is C6H3Cl2I, and its molecular weight is 272.9 g/mol.
How can I request a quotation for 2,5-Dichloroiodobenzene?
Send an inquiry for 2,5-Dichloroiodobenzene (CAS 29682-41-5) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for 2,5-Dichloroiodobenzene
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.